Product Information

TELMISARTAN 20 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1039 per EA under NDC 62332008730. Its NADAC has been published 524 times since Aug 10, 2016.

FDA first approved this application on Jul 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN 20 MG TABLET

Telmisartan
$0.1039per EA

Strength

20 mg/1

NDC

62332008730

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA202130

FDA Approved

7/7/2014

TE Code

AB

On Market Since

6/25/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 20 MG TABLET has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1039 per EA
All-time high$0.6122 (Mar 11, 2020)
All-time low$0.1038 (Jul 22, 2026)
52-week high$0.1163
52-week low$0.1038
Median price$0.3577
Average price$0.3169
Largest weekly change+40.2% (Mar 20, 2019)
Weeks tracked524
Tracking sinceAug 10, 2016

Price History

1W

+0.0%

1M

+0.0%

3M

-1.9%

6M

-1.1%

1Y

-10.7%

3Y

-45.9%

5Y

-74.6%

All

-81.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 20 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1039 per EA (NDC 62332008730), effective Aug 19, 2026.

How has the price of TELMISARTAN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 20 MG TABLET has declined 81.3%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 20 MG TABLET?

Since Aug 10, 2016, the NADAC for TELMISARTAN 20 MG TABLET has ranged from a low of $0.1038 (Jul 22, 2026) to a high of $0.6122 (Mar 11, 2020), with a median of $0.3577 per EA.

Are there cheaper alternatives to TELMISARTAN 20 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN 20 MG TABLET?

TELMISARTAN 20 MG TABLET (NDC 62332008730) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.